Samil Pharmaceutical Co Ltd
000520
Company Profile
Business description
Samil Pharmaceutical Co Ltd is engaged in the manufacture and sale of pharmaceuticals and quasi-drugs and related businesses, and its main products and goods include Polybutin, Gliptide, Brufen, Ribact, and Hiabaks.
Contact
155 Hyoryeong-ro
Bangbae-dong, Samil Pharmaceutical Building
Seocho-Gu
Seoul
KORT: +82 25200300
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
598
Stocks News & Analysis
stocks
2 ASX shares that benefit from sticky inflation
Inflation is a key risk to shareholders. Here’s why these two ASX shares benefit from higher inflation.
stocks
Undervalued ASX retailer benefiting from rebound in spending
Uplift in sales momentum continues.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,923.80 | 7.50 | -0.08% |
| CAC 40 | 8,124.88 | 56.26 | 0.70% |
| DAX 40 | 24,229.91 | 43.42 | 0.18% |
| Dow JONES (US) | 48,349.51 | 108.54 | -0.22% |
| FTSE 100 | 9,751.31 | 102.28 | 1.06% |
| HKSE | 25,628.88 | 347.91 | -1.34% |
| NASDAQ | 23,105.12 | 90.05 | -0.39% |
| Nikkei 225 | 50,168.11 | 668.44 | -1.31% |
| NZX 50 Index | 13,408.14 | 1.23 | 0.01% |
| S&P 500 | 6,816.41 | 11.00 | -0.16% |
| S&P/ASX 200 | 8,635.00 | 8.90 | -0.10% |
| SSE Composite Index | 3,867.92 | 21.42 | -0.55% |